The Legionella pneumophila dotA gene is required for intracellular growth of the bacterium in macrophages. In this study, a structure-function analysis of the DotA protein was conducted to elucidate the role of this protein in L. pneumophila pathogenesis. Translational fusions of dotA to the Escherichia coli phoA and lacZ genes indicated that DotA is an integral cytoplasmic membrane protein with eight membrane-spanning domains. DotA contains two large periplasmic domains of approximately 503 and 73 amino acids and a carboxyl-terminal cytoplasmic domain of 122 amino acids. Protein fractionation studies were consistent with DotA residing in the inner membrane. An alkaline phosphatase fusion located 9 amino acids upstream from the C terminus of DotA still retained function and was able to restore intracellular growth when harbored by two L. pneumophila dotA mutants. A hybrid protein from which the carboxyl-terminal 48 amino acids of DotA were deleted was unable to complement the intracellular growth defect in the dotA mutants, indicating that this cytoplasmic region is required for function.
Legionella pneumophila is a gram-negative respiratory pathogen that grows within alveolar macrophages (24) . In humans, Legionella infections can result in a pneumonia known as Legionnaires' disease or the flu-like syndrome Pontiac fever (13, 27) . Bacteria unable to grow within macrophages have been shown to be avirulent in an animal model for disease (22) .
Following uptake of L. pneumophila by macrophages, bacteria remain within membrane-bound phagosomes that have altered intracellular trafficking properties compared to those of phagosomes harboring nonpathogens (20) . Phagosomes containing avirulent bacteria are normally acidified after uptake and fuse with lysosomal compartments inside the macrophage. The L. pneumophila phagosome, however, is not acidified and does not fuse with lysosomes (21, 23) . Instead, L. pneumophila phagosomes recruit mitochondria to the cytoplasmic surface of the phagosome shortly after uptake and 3 to 6 h afterward associate with the rough endoplasmic reticulum in the cell (20, 38) . This trafficking pathway results in a ribosomestudded compartment known as the replicative phagosome (20, 38) . Formation of this compartment appears to be required for intracellular replication, although the molecular mechanisms used by the bacteria to establish this unique structure inside the cells are unknown.
Genetic studies have identified a cluster of genes required for intracellular replication of L. pneumophila (2, 5) . Of the mutants isolated in one study, those exhibiting the most severe defects in intracellular growth were shown to be defective for formation of the replicative phagosome. These mutants could be complemented in trans by a single open reading frame called dotA (defective organelle trafficking) (3), predicted to encode a protein of 1,048 amino acids. Database searches failed to identify any regions of homology between DotA and other protein sequences. The dotA gene is located adjacent to the icmWXYZ operon on the L. pneumophila chromosome (5) . Like dotA, mutations in the icmWXYZ region result in bacteria that are defective for growth inside macrophages (5, 32) .
To begin to understand the role of DotA protein during intracellular growth of L. pneumophila, we detail here a molecular characterization of the dotA product. Hybrid proteins containing N-terminal dotA sequences and C-terminal phoA or lacZ sequences were used to determine the location and topological orientation of DotA in the bacterial cell (4, 30, 31) . These studies show that DotA is an integral cytoplasmic membrane protein that traverses the membrane eight times. The finding that DotA is an inner membrane protein suggests that DotA works in association with other proteins to transmit a signal to the macrophage to direct the trafficking of the L. pneumophila phagosome.
MATERIALS AND METHODS
Strains and media. L. pneumophila LP02 (thyA hsdR rpsL) is a streptomycinresistant thymine auxotroph derived from the serogroup 1 strain Philadelphia 1 (2) . L. pneumophila LP03 (thyA rpsL hsdR dotA03) and LP053 (thyA rpsL hsdR dotA053) are dotA derivatives of LP02 unable to grow within macrophages (2) . L. pneumophila strains were grown in AYE broth [1% yeast extract, 1% N-(2-acetamido)-2-aminoethanesulfonic acid (ACES; pH 6.9), 3.3 mM L-cysteine, 0.33 mM Fe(NO 3 ) 3 ] or on charcoal-yeast extract (CYE) plates (AYE containing 1.5% Bacto Agar, 0.2% activated charcoal) (11) . When required, the following supplements were added to the media: thymidine at 100 g/ml and streptomycin at 100 g/ml.
Construction of gene fusions with dotA. The signal sequence-deficient phoA gene was removed from the plasmid pCH40 (18) as a PstI fragment and ligated into the plasmid pSK(Ϫ) (Stratagene) at the PstI site. Following electroporation into Escherichia coli DH5␣ (recA1 endA1 gyrA hsdR17 supE44 thi-1 relA1 ⌬(lacIZYA-argF)U169 deoR), recombinant clones were screened by restriction digestion. A plasmid, pSK40C, that had the 5Ј end of the phoA gene adjacent to the BamHI site in pSK(Ϫ), was identified. The phoA fragment was then removed from this plasmid and used to construct each of the dotA::phoA fusions in this study.
The plasmid pKB6 contains the dotA gene on an RSF1010 plasmid that can be transferred by conjugation from E. coli and then replicate in L. pneumophila (3) . To construct the dot309::phoA fusion, pKB6 was digested with BamHI and SalI. The vector backbone encoding the N-terminal region of DotA was purified free from the 2.2-kb insert containing the 3Ј portion of the dotA gene and ligated to a BamHI-SalI fragment encompassing the phoA gene from pSK40C. The ligation was electroporated into DH5␣, and plasmids isolated from ampicillin-resistant clones were screened by restriction enzyme analysis to confirm the construction.
The phoA gene was also ligated to the mutant dotA053 allele present in the plasmid pKB14 (3) by the same approach.
Additional dotA::phoA fusions were constructed with dotA DNA fragments generated by primer-specific amplification with Taq DNA polymerase. The 5Ј primer used in all reactions (5Ј-GGGAGCTCGGTGAGAAAGAATGAATAA ATTAGCT-3Ј) contained a SacI restriction enzyme site followed by the predicted dotA translational initiation region and start codon. The 3Ј primers were homologous to the junction of interest in the dotA gene, and all contained an XbaI site at the 5Ј end of the primer. For instance, the 3Ј primer used to amplify the dotA region used in the dot50::phoA fusion had the sequence 5Ј-CCGTCT AGAGTGCAATACACCATCGAC-3Ј. This combination of primers generated a PCR product encoding the first 50 amino acids in the N-terminal region of DotA flanked by 5Ј SacI and 3Ј XbaI restriction sites. For each amplification reaction, 10 ng of pKB6 digested with SalI was amplified for 20 cycles consisting of melting for 1 min at 94ЊC, annealing for 1 min at 50ЊC, and extension for 2 min at 74ЊC. Amplified DNA product was purified with a QIAquick spin PCR kit (QIAGEN, Inc.) followed by digestion with SacI and XbaI. The amplified dotA region was fused upstream of phoA by replacing the SacI-XbaI fragment encoding the existing dotA region in pdot309::phoA and replacing it with the PCRgenerated dotA fragment. To construct dotA::lacZ fusion plasmids, the phoA gene was removed from each pdotA::phoA plasmid by digestion with SmaI and SalI and replaced with the lacZ gene removed from plasmid pMC1871 (7) as a SmaI-SalI fragment. For construction of the dotA deletion fusions, a 3Ј primer (5Ј-GGGAATTCCGCAATCAAAATCCTGGTG-3Ј) was used in conjunction with the 5Ј primer above to generate a DNA fragment encoding the aminoterminal 611 amino acids of DotA. This DNA fragment was digested with the restriction enzymes EcoRI and SacI prior to ligation. The carboxyl regions of the dotA deletions were generated with either a 5Ј primer homologous to the dotA region encoding amino acids 845 to 850 (5Ј-CGGAATTCAATCGGATCAAG GAATAG-3Ј) or the 948-to-953 region (5Ј-CGGAATTCCGGAATCTTTTGG TCAAG-3Ј). These 5Ј primers were used in conjunction with the appropriate 3Ј primers described above to generate carboxyl-terminal fusions to the dotA gene. These DNA fragments were digested with EcoRI and XbaI prior to ligation. The amino-terminal and desired carboxyl-terminal dotA fragments were then ligated in frame with the phoA gene in pdot309::phoA vector as described above.
The dotA::phoA and dotA::lacZ plasmids were mated into L. pneumophila by triparental conjugations with the E. coli strains DH5␣ containing the fusion plasmid and MT607 (pRK600) (12) providing the broad-host-range transfer functions. The three strains were lightly patched onto CYE plates, and the plates were incubated for 4 h at 37ЊC. The conjugation mix was then swabbed into distilled water (dH 2 O), and dilutions were plated onto CYE containing streptomycin to select against the E. coli donors and lacking thymidine to select L. pneumophila exconjugants. The fusion plasmids contain a copy of the thymidylate synthetase gene and are therefore able to restore growth of the L. pneumophila thyA recipients.
Alkaline phosphatase and ␤-galactosidase assays. L. pneumophila strains containing pdotA::phoA fusions were grown to saturation in AYE broth at 37ЊC and then diluted into fresh AYE to a final optical density at 600 nm (OD 600 ) of 0.2. The cultures were further incubated for 6 to 8 h at 37ЊC, and then isopropyl ␤-D-thiogalactopyranoside (1 mM) was added to induce expression of the fusion proteins from a 5Ј ptac promoter. After 1 h, alkaline phosphatase activity was determined by pelleting 1 ml of bacteria and resuspending the cells in 1 ml of 0.1 M CAPS (3-[cyclohexylamino]-1-propanesulfonic acid [pH 11.0]) (1). The assay mixture consisted of 0.1 ml of bacterial cells, 0.9 ml of 0.1 M CAPS (pH 11.0), and 0.1 ml of Sigma 104 (0.4% in 0.1 M CAPS [pH 11.0]). The reaction mixtures were incubated at 37ЊC until a yellow reaction product was visible, at which time 0.1 ml of 1 M K 2 HPO 4 was added to terminate the reaction. Bacteria were pelleted in an Eppendorf tube, and the OD 420 of the supernatant was measured. Alkaline phosphatase units were determined by the formula (1,000 ϫ OD 420 of reaction)/[(minutes of reaction) (bacterial OD 600 )]. The same growth conditions were used for ␤-galactosidase assays, and ␤-galactosidase activities were determine as described by Miller (33) .
Immunoblotting. Whole-cell L. pneumophila extracts were made from the identical broth cultures used to determine alkaline phosphatase activity. Bacteria (OD 600 1.0) were pelleted in a microcentrifuge, and the pellets were resuspended in 200 l of sample buffer at 4ЊC (29) . The whole-cell extract was then either boiled for 5 min or incubated for 1 h on ice prior to sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). Following gel electrophoresis, the proteins were transferred onto Immobilon P (Millipore Corp.) membranes in transfer buffer (50 mM Tris, 380 mM glycine, 0.1% SDS, 20% methanol [pH 8.3]) at 20 V for 12 h. Filters were washed in phosphate-buffered saline (PBS), blocked for 1 h in PBS containing 5% nonfat dried milk (Blotto), and probed for 1 h with a rabbit polyclonal anti-alkaline phosphatase antibody (1:1,000) in Blotto. Alkaline phosphatase-conjugated goat anti-rabbit immunoglobulin G (Zymed Laboratories, Inc.) was used as the secondary antibody, and the blot was developed with 5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazolium (Sigma) (16) .
Rabbit antibodies against DotA were generated with a peptide corresponding to DotA amino acids 542 to 557 (Zymed Laboratories Custom Antibody Service). The resulting antiserum was affinity purified then diluted 1:100 for detection of DotA on Western blots by using horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (Bio-Rad) and the ECL (Amersham) reagent to detect DotA product.
Cellular fractionation. Triton X-100 solubilization of membrane-associated proteins. L. pneumophila cultures (50 ml) were grown in AYE broth to midlogarithmic phase (OD 600 ϭ 1.5) and pelleted at 5,000 ϫ g for 10 min. All subsequent steps were performed at 4ЊC. The bacteria were resuspended in 0.5 ml of ice-cold 200 mM Tris HCl (pH 8.0) and 0.5 ml of ice-cold sucrose buffer (50 mM Tris HCl [pH 8.0], 1 M sucrose) was then added. Spheroplasts were made by adding 10 l of 0.5 M EDTA (pH 8.0) and 10 l of 10 mg of lysozyme per ml. The suspension was then diluted to 2 ml with the addition of 1 ml of dH 2 O. After 30 min, MgSO 4 was added to a final concentration of 20 mM, and the spheroplasts were pelleted for 10 min at 5,000 ϫ g. The cells were resuspended in 5 ml of 50 mM Tris HCl (pH 8.0) and lysed on ice by sonication with a Branson Sonicator model 250. Typically, three sonic bursts at 25 to 50% intensity (each 15 s in duration) were sufficient to lyse the bacteria. Unlysed cells were removed by centrifugation for 10 min at 5,000 ϫ g. The supernatant containing both soluble and membrane-associated proteins was the total cellular protein extract (Fraction T). Cellular membrane was then pelleted at 100,000 ϫ g for 1 h. Soluble proteins were removed and saved (fraction S). The cellular membrane fraction was gently resuspended in 1 ml of 50 mM Tris HCl (pH 8.0). Triton X-100 (10% solution) was slowly added to the membrane suspension to a final concentration of 1%, and the membrane solution was incubated on ice for 30 min. The suspension was centrifuged for 30 min at 100,000 ϫ g, and the Triton X-100 soluble proteins were carefully removed (fraction I). The pellet was resuspended in 1 ml of 50 mM Tris-HCl (pH 8.0) (fraction O). For detection of DotA, equivalent volumes (20 l of fractions T and S and 4 l of fractions I and O) were diluted into Laemmli buffer and incubated on ice for 30 min. DotA was then identified on Western blots using anti-DotA antibody as described above. To detect L. pneumophila major outer membrane protein (MOMP), equivalent volumes of each fraction were diluted into Laemmli buffer, boiled for 5 min, and separated on an SDS-15% polyacrylamide gel. The proteins were stained with Coomassie brilliant blue, and MOMP was identified as an intense band at ϳ28 kDa (15) .
The protocol used for sucrose gradient fractionation of L. pneumophila membranes was modified from the procedure described by Ishidate et al. (25) . All sucrose solutions, for which values are given on a weight-per-weight basis, contained 10 mM HEPES and 5 mM EDTA (pH 7.6). For membrane isolation, 100 ml of bacteria was grown in AYE (OD 600 ϭ 0.8). The bacteria were pelleted at 5,000 ϫ g for 15 min at 4ЊC and washed once in 10 ml of ice-cold 10 mM HEPES (pH 7.6). The final pellet was resuspended in 5 ml of ice-cold 20% sucrose containing 10 mM HEPES (pH 7.6), 2 g of DNase per ml, and 10 g of RNase per ml. The cells were disrupted by a single passage through a chilled French pressure cell at 10,000 lb/in 2 . Unbroken cells were removed by centrifugation at 2,000 ϫ g for 15 min at 4ЊC. EDTA (pH 8.0) was added to the lysate to a final concentration of 5 mM.
A crude membrane fraction was obtained by loading 1.5 ml of the bacterial lysate onto a two-step gradient consisting of 0.8 ml of a 60% sucrose cushion and 2.5 ml of 25% sucrose. The membranes were pelleted for 3.5 h at 40,000 rpm in an SW50.1 rotor at 4ЊC. A membrane layer visible on top of the 60% sucrose was extracted into a 1-ml syringe by puncturing the side of the tube with an 18-gauge needle. This crude membrane fraction was diluted to 25% sucrose with 10 mM HEPES (pH 7.6).
Isopyncnic sucrose density gradient centrifugation of the crude membrane was carried out on a gradient consisting of a 0.5-ml cushion of 55% sucrose and layers of 2.1 ml of 50, 45, 40, 35, and 30% sucrose. Approximately 0.8 ml of the crude membrane prep was placed on top of the gradient and centrifuged in an SW41 rotor at 37,000 rpm for 16 h at 4ЊC. Fractions (150 l) were collected by gravity flow from the bottom of the centrifuge tube following puncture of the tube with an 18-gauge needle. Levels of the 28-kDa MOMP and the 65-kDa major cytoplasmic membrane protein (MCMP) were determined by Coomassie blue staining of SDS-15% PAGE gels containing 10 l of each sucrose gradient fraction per lane. With an Apple Power PC computer and an integrated charge-coupled digital camera, images of the gels were captured and pixel intensities in the areas corresponding to the location of each protein were determined with NIH Image 1.54. Measurements of DotA levels were determined by immunoblot analysis of the fractions as described for DotA above; however, the fluorescent alkaline phosphatase substrate Attophos (JBL Scientific) was used for detection in these experiments. The washed blots were placed on top of 1 ml of Attophos substrate Growth of L. pneumophila in U937 cells. U937 cells were passaged and differentiated with phorbol 12-myristate 13-acetate (Sigma) as described elsewhere (35) . L. pneumophila strains were grown in AYE broth to early stationary phase. Approximately 5 ϫ 10 9 bacteria were pelleted and resuspended in 1 ml of dH 2 O (OD 600 ϭ 1). This suspension of bacteria was then diluted 1:20 into RPMI tissue culture media. The bacteria (2 l) were then added to differentiated U937 cells (2 ϫ 10 6 per well) in 24-well dishes to give a multiplicity of infection of about 0.25. The bacteria were incubated with the U937 cells for 1 h, and the U937 cell monolayer was then washed several times with PBS to remove excess bacteria. Fresh tissue culture medium was added to the wells, and the U937 cells were maintained at 37ЊC in 5% CO 2 . To measure intracellular replication of L. pneumophila, the bacteria were liberated by lysis of the U937 cells in dH 2 O at various time points, and dilutions were plated onto CYE plates to measure CFUs.
RESULTS
DotA is an integral inner membrane protein with eight transmembrane domains. The DotA protein was postulated to associate with lipid bilayers based on a large hydrophobic domain in the C-terminal half of the protein (3). Further examination of the DotA amino acid sequence revealed that the DotA protein has structural characteristics of an integral cytoplasmic membrane protein. Eight amino acid regions in the DotA protein of sufficient length and hydrophobic potential to span the membrane were identified when the hydopathic profile of the protein was plotted with the Kyte-Doolittle scale and a window size of 19 ( Fig. 1) (28) .
To analyze whether the putative transmembrane domains identified in the DotA protein translocate regions of the protein across the cytoplasmic membrane, the signal sequencedeficient alkaline phosphatase gene (phoA) from E. coli was fused in frame to the dotA coding region at numerous Cterminal positions. To serve as a negative control, the phoA gene was ligated to the dotA53 allele at the codon predicted to encode amino acid residue 309 in the dotA gene. The dotA53 allele is defective for function due to a frameshift mutation resulting in an N-terminally truncated protein of only 230 amino acids. Alkaline phosphatase activity for each of the hybrid DotA::PhoA proteins was measured to assess translocation of the PhoA moiety to the periplasmic side of the cytoplasmic membrane.
The DotA::PhoA fusion results suggested that DotA contains distinct domains on opposite sides of the cytoplasmic membrane, as demonstrated by the oscillation in alkaline phosphatase activity as phoA fusions are extended from N-to Cterminal regions in the DotA protein (Fig. 2) . A phoA fusion junction located at residue 50 in the DotA protein (Dot50::PhoA) had high alkaline phosphatase activity. This result is consistent with the predicted location of the first transmembrane domain (TM1) in DotA spanning amino acids 4 to 19 with the carboxyl-terminal portion directed toward the periplasm. The second DotA transmembrane domain (TM2) predicted to span amino acids 66 to 85 should return the protein to the cytoplasmic side of the inner membrane. The data showed that DotA::PhoA fusion junctions at amino acid position 100 or 119 exhibited low alkaline phosphatase activity, in agreement with the predicted location of TM2. DotA::PhoA fusion junctions at amino acid positions 150, 200, 309, 450, 546, 611, and 650 all had high alkaline phosphatase activities, indicating that a DotA transmembrane domain predicted to span amino acids 118 to 138 (TM3) is able to translocate a large region of the protein back across the cytoplasmic membrane.
The region in the DotA protein between amino acids 650 and 850 is very hydrophobic and is predicted to contain four transmembrane domains. A DotA::PhoA fusion junction at amino acid 700 results in low alkaline phosphatase activity, indicating that a transmembrane domain predicted to span amino acids 647 to 667 (TM4) returns this region of the DotA protein to the cytoplasmic side of the inner membrane. There is a transmembrane domain predicted to be present in the DotA protein from amino acids 719 to 739 (TM5) followed by another predicted transmembrane domain that spans amino acids 753 to 773 (TM6). Internal to TM5 and TM6 would be a 13-amino-acid periplasmic loop. Hybrid proteins containing DotA::PhoA fusion junctions within this periplasmic loop at amino acid position 750 or 755 did not exhibit alkaline phosphatase activity significantly above baseline, whereas a DotA::PhoA fusion constructed at amino acid position 760 resulted in alkaline phosphatase activity approximately sixfold above background. The Dot760::PhoA fusion contains the Nterminal 8 amino acids predicted to be present in TM6, which would interact with phospholipids on the periplasmic leaflet of the inner membrane. This interaction may stabilize the formation of the adjacent 13-amino-acid periplasmic loop aiding the translocation of the alkaline phosphatase moiety in the Dot760::PhoA fusion protein. These data suggest that TM5 requires a portion of TM6 to present the 13-amino-acid region to the periplasmic face of the inner membrane.
The alkaline phosphatase activities of PhoA hybrids constructed at DotA amino acids 765, 770, 774, and 793 were at baseline values, indicating that the predicted TM6 mediates translocation of these regions to the bacterial cytoplasm. The predicted transmembrane domain from amino acids 813 to 833 (TM7) oriented alkaline phosphatase to the periplasm for fusion junctions at DotA amino acids 863 and 900. The transmembrane domain from amino acids 906 to 926 (TM8) localizes the C terminus of DotA to the cytoplasm, as demonstrated by DotA::PhoA fusions made at amino acids 950, 1000, and 1039, all of which had low alkaline phosphatase activity.
With an antibody directed against the alkaline phosphatase portion of the fusion proteins, Western blots of L. pneumophila strains solubilized in Laemmli buffer at 4ЊC were examined to verify that each of the DotA::PhoA fusions were being expressed. Full-length DotA::PhoA proteins were detected for all of the fusions (Fig. 3) . Alkaline phosphatase fusions made to the large periplasmic region of DotA (fusions 150 to 650) appear to be more stable than fusions to other regions of the protein; however, this 2-to 3-fold increase in protein does not account for the greater-than-30-fold increase in alkaline phosphatase activity measured for these fusions in vivo. These data indicate that the large variations in activity measured for the different fusions were due to oscillations in the cellular localization of the alkaline phosphatase moiety of the hybrids. It should be noted that DotA::PhoA fusion proteins C terminal to TM4 were difficult to visualize on Western blots when the extracts were heated to 100ЊC in SDS buffer rather than 4ЊC prior to SDS-PAGE (data not shown), an observation that has been reported for a number of inner membrane proteins (6, 26, 36) . To corroborate that fusions resulting in low alkaline phosphatase activity had fusion joints located in cytoplasmic domains of DotA, the phoA gene was replaced with an in-frame lacZ fusion. The resulting fusion proteins should exhibit high ␤-galactosidase activity only when the lacZ gene is fused to a cytoplasmic region of the DotA protein (30) . The data show that for any given fusion junction within DotA, ␤-galactosidase activity is inversely proportional to alkaline phosphatase activity (Fig. 4) .
DotA internal deletions resulting in altered membrane topology. To test the topology predictions of the C terminus of DotA, an internal deletion encompassing amino acids 611 to 846 was made to remove all transmembrane domains from this large hydrophobic region. According to the above data, this deletion should result in the removal of four transmembrane domains. Localization of regions of the protein C terminal to the deletion should not be affected by the removal of an even number of transmembrane domains. To determine the effect of this alteration on DotA protein topology, this deletion was introduced into DotA::PhoA fusions having junctions at residues 900, 1000, and 1039 in the wild-type DotA protein (Fig.  5) . The DotA⌬611-846::PhoA fusion at residue 900 retained high alkaline phosphatase activity, indicating that localization of this region is not altered by the deletion. DotA⌬611-846 also failed to alter the activity of fusions with junctions at residues 1000 and 1039, which retained baseline levels of alkaline phos- The hydrophobic stretch in the DotA protein between amino acids 906 and 926 should encode the transmembrane region (TM8) required for cytoplasmic localization of the DotA C terminus. To verify this prediction, a deletion between residues 611 and 950 was constructed, resulting in the removal of five predicted transmembrane regions (TM4 to TM8). Alkaline phosphatase fusions at residues 1000 and 1039 of the wild-type DotA protein were constructed C-terminally to the deletions, and activity was determined. Both of the DotA⌬611-950::PhoA fusion proteins had alkaline phosphatase activities significantly higher than those of their counterpart DotA⌬611-846::PhoA fusion proteins (Fig. 5) . Immunoblot analysis (Fig. 3) demonstrates that following the internal dotA deletions, expression of the fusion proteins in L. pneumophila was observed. The switch in alkaline phosphatase activity is, therefore, consistent with the model that DotA⌬611-950 removes an odd number of transmembrane regions, causing a switch in the localization of the PhoA moiety from a cytoplasmic to a periplasmic compartment.
The DotA protein has the fractionation properties of an inner membrane protein. Cellular fractionation studies were used to further characterize the localization of DotA. Logorithmically growing cells of L. pneumophila LP02 (dotA ϩ ) and LP053 (dotA053) were lysed by lysozyme-sonication treatment, total cellular membrane was pelleted, and inner and outer membrane proteins were differentially extracted in Triton X-100 (37) and analyzed by Western blotting with an antiDotA antibody. The DotA protein is clearly expressed in L. pneumophila LP02 but not in the dotA mutant LP053 (Fig. 6A) , which is predicted to synthesize a protein that is truncated amino terminally to the DotA542-557 epitope recognized by the antibody (the prominent band seen below the 97-kDa marker is an unknown L. pneumophila protein that cross-reacts with the horseradish peroxidase-conjugated secondary antibody). In LP02, DotA protein is found exclusively in the membrane fractions. The majority of the DotA protein present in the membrane fraction becomes soluble following extraction of the membranes with 1% Triton X-100 (Fig. 6, lanes I and O,  LP02 ). Protein profiles were also examined for each cellular fraction by Coomassie staining of the acrylamide gels (Fig. 6B) . In contrast to DotA, the outer membrane protein MOMP remains insoluble following 1% Triton X-100 extraction (15) . To further characterize the localization of the DotA protein, L. pneumophila membranes were separated by centrifugation on a sucrose gradient (Fig. 7) . In agreement with the Triton X-100 data, these results show that DotA and MOMP reside in distinct membrane fractions.
The DotA cytoplasmic C terminus is required for in vivo function. The plasmids encoding the DotA::PhoA hybrid proteins were mated into LP03 and LP053 to determine if intracellular growth of the bacteria could be restored in phorbol ester transformed U937 cell cultures (2). The Dot1039::PhoA protein was the only hybrid capable of restoring intracellular growth to LP03 (dotA03 is a nonsense mutation that inserts a termination codon at amino acid 188) or LP053, whereas the plasmids containing an alkaline phosphatase fusion to DotA amino acid 309, 450, 546, 611, 793, 863, 900, 950, or 1000 or any of the five deletion constructs were all unable to complement these two chromosomal mutations ( Fig. 8 ; data not shown). The Dot1039::PhoA protein was missing the nine C-terminal amino acids of DotA, yet restored intracellular growth to levels equivalent to that of the wild-type DotA protein (Fig. 8) . In contrast, the Dot1000::PhoA protein, missing 48 C-terminal amino acids, was unable to complement the chromosomal dotA mutation (Fig. 8) . The inability to restore intracellular growth with the Dot1000::PhoA hybrid indicates that the cytoplasmic C terminus has an important role in DotA function.
The plasmids expressing the DotA::PhoA hybrid proteins were also placed into L. pneumophila LP02 (dotA ϩ ), and none had a detectable effect on intracellular replication (data not shown). These results indicate that introduction of multiple copies of each of the defective DotA proteins does not interfere with the function of the chromosomal dotA gene product.
DISCUSSION
The dotA gene of Legionella pneumophila is required for intracellular growth of the bacteria in macrophages and is also necessary for recruitment of host cell organelles to the phagosomal membrane (2, 3, 38) . The molecular mechanisms employed by L. pneumophila to subvert the host-cell defenses and direct a distinctive phagosome trafficking pathway inside the cell are unknown. In this study, we have undertaken a molecular characterization of the dotA gene product. The dotA sequence and translated gene product show no obvious homologies to other sequences in the current databases, although our analysis suggests topological similarities to inner membrane transport proteins. By constructing sequential C-terminal PhoA protein fusions to DotA, the topological organization of the DotA protein within the inner membrane is predicted to contain eight transmembrane helices. These membrane-spanning regions are also predicted by the hydropathic characteristics of the protein (28) and by the TopPred II computer algorithm developed by von Heijne which uses the positive-inside rule favoring conformations that contain basic amino acid residues near the cytoplasmic face of the inner membrane (8, 39) .
Based on studies of fusions to alkaline phosphatase and ␤-galactosidase, there are three transmembrane domains located in the N terminus of DotA between amino acids 1 and 150 (Fig. 9) . These transmembrane domains are predicted to present a large periplasmic domain of 509 amino acids that contains 10 of the 12 cysteine residues found in the DotA protein, suggesting the presence of multiple disulfide bonds. This periplasmic domain is N terminal to a hydrophobic region in the DotA protein that is predicted to contain four transmembrane helices. The second periplasmic domain of significant size is located between amino acids 833 and 906. An eighth transmembrane domain exists that is required for the localization of the carboxyl-terminal 122 amino acids of DotA to the cytoplasm.
We failed to isolate dotA::phoA fusions between the fifth and sixth transmembrane domains (TM5 and TM6) that have high alkaline phosphatase activity. The periplasmic loop between TM5 and TM6 is predicted to be 13 amino acids in length, the shortest loop in the DotA protein. Proper localization of these 13 amino acids may require some form of cooperative interaction between TM5 and TM6. The Dot760::PhoA fusion protein contains eight amino acids of the predicted TM6 (Fig. 9) and is the only hybrid protein containing a fusion junction in this region that demonstrated alkaline phosphatase activity significantly above the baseline. These data suggest that the eight amino acids of TM6 may provide enough secondary structure for membrane insertion of TM5 and yet are not sufficient to mediate complete translocation of the protein back to the cytoplasm. An alternative explanation is that this region could be important for translocation of a substrate across the inner membrane and therefore be more fluid in its membrane interactions.
The predicted locations of transmembrane domains in DotA are similar to the arrangement of transmembrane domains in members of the ABC-type transporter proteins (17) , which include the MalF protein. Although only about half of the size of DotA, MalF also has eight transmembrane domains, a large periplasmic domain between TM3 and TM4, and a cytoplasmic C terminus (4, 14) . MalF is required for the transport of maltose from the E. coli periplasm to the cytoplasm. This process requires several additional proteins, the periplasmic maltose binding protein MalE, a second inner membrane component, MalG, and the cytoplasmic nucleotide-binding protein MalK (9, 10, 19, 34) . However, the function of DotA does not appear to be at the level of importing an essential nutrient to bacteria once inside of macrophages. An L. pneumophila thymine auxotroph is defective for intracellular replication, as would be expected for a mutant defective in uptake or biosynthesis of a critical metabolite, and yet is able to form a replicative phagosome following uptake by macrophages in the absence of thymine (2) . In contrast, dotA mutants are defective in the formation of replicative phagosomes (2, 3, 38) , and their defect in targeting is apparent within 5 min following uptake of the bacterium into the macrophage (36a). The kinetics of this defect is, therefore, inconsistent with DotA protein being involved in a metabolic pathway.
The architectural similarity between DotA and ABC transporters suggests that DotA may also interact with other proteins as part of a complex required for intracellular targeting of the phagosome inside macrophages. The predicted DotA structure contains three spatially defined domains. The two periplasmic domains may interact with each other or mediate protein-protein interactions with either periplasmic or outer membrane-associated components.
The eight DotA transmembrane domains could interact to form a portal between the cytoplasm and the periplasm. The cytoplasmic domains of dotA may have a regulatory role, serving as a link between energy-transducing proteins in the cytoplasm and the extracellular milieu. Recent results from analysis of mutants defective for intracellular growth indicate that there is at least one protein predicted to have nucleotide binding capacity that may serve to transduce energy to a complex containing DotA protein (38a).
The icmWXYZ gene products are also attractive candidates for components that could work in association with DotA for the following reason. The icmWXYZ operon is found immediately adjacent to the dotA locus, and these genes are also required for growth of L. pneumophila inside macrophages (5, 32) . It is clear that genes encoding pathogenic determinants in bacteria can often be found clustered either on the chromosome or on plasmids. Therefore, the proximity of the icm operon to dotA and the similar intracellular growth defects resulting from mutations in either region suggest that these genes may all encode a multiprotein system that is required for the establishment of a replicative niche once L. pneumophila cells are ingested by macrophages.
